Industry
To win in the rare disease space, pharmaceutical companies need a unique business model and a carefully tailored set of capabilities across R&D, market access and customer engagement. We work with you to develop the strategy and operating model essential to succeed in this winner-takes-all market.
Insights
Covid-19
As the human cost of COVID-19 rises the global pandemic is also sending shockwaves through the world economy. But, across industries and around the world, companies can take important actions now to protect the safety and health of their employees and customers, and mitigate the economic damage.
Learn more
What We Do
What We Do
Bain works with leading biopharmaceutical companies in the rare disease market to:
- Design organizations that excel in rare diseases, from enterprise operating model and executive governance to commercial structures and ways-of-working
- Accelerate speed-to-market by building fit-for-purpose research & development operating models, processes and infrastructure
- Define the path and capabilities required to achieve a leadership position, and drive sustainable, profitable growth, including through transformative acquisitions
- Prepare for rare disease drug launches that create maximum value, effectively navigating a marketing and access landscape that is unique to rare diseases
- Create new pricing and access strategies for rare disease assets
- Drive operational efficiencies to unlock savings and enable investments in line with your highest strategic priorities
